Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pharmacokinetic Equivalence
100%
Salicylate
100%
Bepotastine Besilate
100%
Bepotastine
100%
Cmax
50%
Test Formulation
37%
Adverse Events
25%
Treatment Duration
25%
Ratio of Means
25%
Pharmacokinetic Parameters
25%
Bioequivalence
25%
AUC Value
25%
Pharmacokinetics
12%
No Significant Difference
12%
Plasma Concentration
12%
Confidence Interval
12%
Allergic Rhinitis
12%
Pharmacokinetic Profile
12%
Regulatory Requirements
12%
Two-period
12%
Mean Standard Deviation
12%
Healthy Participants
12%
Area under the Concentration-time Curve
12%
Regulatory Criteria
12%
Drug Treatment
12%
Healthy Males
12%
Plasma Samples
12%
Geometric Mean
12%
Single Center
12%
Skin Diseases
12%
Washout Period
12%
Pruritus
12%
Drug Analysis
12%
Urticaria
12%
Histamine H1 Receptor Antagonist
12%
Pharmacology, Toxicology and Pharmaceutical Science
Salicylic Acid
100%
Normal Human
100%
Bepotastine
100%
Pharmacokinetics
100%
Adverse Event
18%
Pharmacokinetic Parameter
18%
Bioequivalence
18%
Base
9%
Allergic Rhinitis
9%
Pharmacotherapy
9%
Pruritus
9%
Urticaria
9%
Skin Disease
9%
Histamine H1 Receptor Antagonist
9%
Drug Analysis
9%